Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravindra Kumar

Showing results (791-800 of 888) with videos related to

Pageof 89
Sort By:
Water Research|February 1, 2016
Polymer functionalized nanocomposites for metals removal from water and wastewater: An overviewGiusy Lofrano, Maurizio Carotenuto, Giovanni Libralato, et al.
Blood|May 6, 2014
Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemiaRajasekhar N V S Suragani, Sharon M Cawley, Robert Li, et al.
Indian Pediatrics|January 16, 2020
Newborn Screening and Diagnosis of Infants with Congenital Adrenal HyperplasiaPallavi Vats, Aashima Dabas, Vandana Jain, et al.
Physical Review Letters|September 26, 2012
Macroscopic transport of mega-ampere electron currents in aligned carbon-nanotube arraysGourab Chatterjee, Prashant Kumar Singh, Saima Ahmed, et al.
NPJ Parkinson'S Disease|November 18, 2024
Circulating blood circular RNA in Parkinson's Disease; from involvement in pathology to diagnostic tools in at-risk individualsAleksandra Beric, Yichen Sun, Santiago Sanchez, et al.
Bone|January 19, 2010
A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeysSutada Lotinun, R Scott Pearsall, Monique V Davies, et al.
Science Advances|April 19, 2023
Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectorsTimothy F Shay, Erin E Sullivan, Xiaozhe Ding, et al.
Molecular Cancer Therapeutics|February 4, 2010
ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growthDianne Mitchell, Eileen G Pobre, Aaron W Mulivor, et al.
Nature Methods|April 22, 2020
Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell typesSripriya Ravindra Kumar, Timothy F Miles, Xinhong Chen, et al.
Nature Protocols|July 18, 2019
Publisher Correction: Systemic AAV vectors for widespread and targeted gene delivery in rodentsRosemary C Challis, Sripriya Ravindra Kumar, Ken Y Chan, et al.
Pageof 89

Showing results (791-800 of 888) with videos related to

Sort By:
Pageof 89
Water Research|February 1, 2016
Polymer functionalized nanocomposites for metals removal from water and wastewater: An overviewGiusy Lofrano, Maurizio Carotenuto, Giovanni Libralato, et al.
Blood|May 6, 2014
Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemiaRajasekhar N V S Suragani, Sharon M Cawley, Robert Li, et al.
Indian Pediatrics|January 16, 2020
Newborn Screening and Diagnosis of Infants with Congenital Adrenal HyperplasiaPallavi Vats, Aashima Dabas, Vandana Jain, et al.
Physical Review Letters|September 26, 2012
Macroscopic transport of mega-ampere electron currents in aligned carbon-nanotube arraysGourab Chatterjee, Prashant Kumar Singh, Saima Ahmed, et al.
NPJ Parkinson'S Disease|November 18, 2024
Circulating blood circular RNA in Parkinson's Disease; from involvement in pathology to diagnostic tools in at-risk individualsAleksandra Beric, Yichen Sun, Santiago Sanchez, et al.
Bone|January 19, 2010
A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeysSutada Lotinun, R Scott Pearsall, Monique V Davies, et al.
Science Advances|April 19, 2023
Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectorsTimothy F Shay, Erin E Sullivan, Xiaozhe Ding, et al.
Molecular Cancer Therapeutics|February 4, 2010
ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growthDianne Mitchell, Eileen G Pobre, Aaron W Mulivor, et al.
Nature Methods|April 22, 2020
Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell typesSripriya Ravindra Kumar, Timothy F Miles, Xinhong Chen, et al.
Nature Protocols|July 18, 2019
Publisher Correction: Systemic AAV vectors for widespread and targeted gene delivery in rodentsRosemary C Challis, Sripriya Ravindra Kumar, Ken Y Chan, et al.
Pageof 89